Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,363.50    -40.00 (-0.91%)
Bid:
4,360.00
Ask:
4,361.00
Spread: 1.00 (0.023%)
Market Cap: £94.49b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Share Buyback Programme

19 Dec 2022 17:45

RNS Number : 2314K
Unilever PLC
19 December 2022
 

Share Buyback Programme - Update December 2022

19/12/2022

London - Unilever PLC confirms the successful completion of the second tranche of €750 million of its programme to buy back shares with an aggregate market value equivalent of up to €3 billion.

On 10 February 2022, Unilever PLC announced its fourth quarter and full year 2021 results and a share buyback programme of up to €3 billion to be conducted over 2022 and 2023. On 6 September 2022, Unilever PLC announced the commencement of the second tranche of the buyback programme for an aggregate market value equivalent to €750,000,000 to be completed by 23 December 2022 (the "Second Tranche").

Unilever PLC confirms the completion of the Second Tranche. Between 6 September 2022 and 19 December 2022, a total of 16,415,133 ordinary Unilever PLC shares were purchased.

Further tranches of the share buyback programme will be announced in due course as appropriate.

Unilever PLC

Unilever House100 Victoria EmbankmentLondon EC4Y 0DYUnited Kingdom

Press-Office.London@Unilever.com

 

 

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance or outcomes.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current Covid-19 pandemic. These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2021 and the Unilever Annual Report and Accounts 2021 available on our corporate website.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBRBDDXSBDGDC
Date   Source Headline
4th Nov 20256:21 pmRNSUpdate on Demerger & Share Consolidation Timetable
3rd Nov 202512:20 pmRNSTotal Voting Rights
30th Oct 20251:34 pmRNSPublication of Final Terms
30th Oct 202512:00 pmRNSStatement re AGM Vote
28th Oct 20254:00 pmRNSDirector/PDMR Shareholding
27th Oct 20255:16 pmRNSDirector/PDMR Shareholding
24th Oct 20254:19 pmRNSPublication Supplement
23rd Oct 20257:00 amRNSQ3 2025 Trading Statement
21st Oct 202510:20 amRNSResult of General Meeting
21st Oct 20257:00 amRNSStatement regarding Demerger & Share Consolidation
7th Oct 202510:42 amRNSAppointment of NED
2nd Oct 20257:00 amRNSShareholder Circular, Notice of General Meeting
1st Oct 20254:35 pmRNSTotal Voting Rights
22nd Sep 20257:00 amRNSDirector/PDMR Shareholding - Amendment
19th Sep 20251:18 pmRNSDirector/PDMR Shareholding
17th Sep 20253:41 pmRNSDirector/PDMR Shareholding
17th Sep 20259:40 amRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSDirectorate Change
15th Sep 202511:57 amRNSBlock listing Interim Review
3rd Sep 20256:07 pmRNSPublication of Final Terms
1st Sep 20254:13 pmRNSTotal Voting Rights
1st Aug 20252:33 pmRNSTotal Voting Rights
31st Jul 20253:03 pmRNSPublication of Supplement
31st Jul 20257:00 amRNS2025 First Half Results
1st Jul 202512:55 pmRNSTotal Voting Rights
1st Jul 20259:35 amRNSDirector/PDMR Shareholding
20th Jun 20253:25 pmRNSDirector/PDMR Shareholding
18th Jun 20252:28 pmRNSDirector/PDMR Shareholding
17th Jun 20254:06 pmRNSDirector/PDMR Shareholding
2nd Jun 20252:18 pmRNSTotal Voting Rights
30th May 20256:29 pmRNSCompletion of Share Buyback
30th May 20256:28 pmRNSTransaction in Own Shares
30th May 20255:36 pmRNSPUBLICATION OF UFN FINANCIAL STATEMENTS
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20259:22 amRNSPublication of Final Terms: Unilever Bonds
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.